Sign In
Buy NKTR
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026
Engineers Gate Manager LP Sells 24,690 Shares of Nektar Therapeutics (NASDAQ:NKTR)
06:52am, Sunday, 27'th Sep 2020
Engineers Gate Manager LP reduced its stake in shares of Nektar Therapeutics (NASDAQ:NKTR) by 63.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchang
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) Director Sells $44,415.00 in Stock
08:36am, Friday, 25'th Sep 2020
Nektar Therapeutics (NASDAQ:NKTR) Director Jeffrey Robert Ajer sold 2,250 shares of the stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $19.74, for a t
Nektar Therapeutics (NASDAQ:NKTR) CFO Sells $39,920.00 in Stock
08:36am, Friday, 25'th Sep 2020
Nektar Therapeutics (NASDAQ:NKTR) CFO Gil M. Labrucherie sold 2,000 shares of the firm’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $19.96, fo
Nektar Therapeutics (NASDAQ:NKTR) Shares Purchased by Canada Pension Plan Investment Board
06:48am, Tuesday, 22'nd Sep 2020
Canada Pension Plan Investment Board boosted its position in Nektar Therapeutics (NASDAQ:NKTR) by 1,184.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The
Nektar Looks Undervalued, But The Biggest Value-Driving Events Are Still In 2021
04:00pm, Friday, 28'th Aug 2020
Nektar is largely marking time ahead of some medium impact trial updates in November and game-changing updates in 2021 for the melanoma and bladder cancer programs.
Gil M. Labrucherie Sells 6,245 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
08:12am, Saturday, 22'nd Aug 2020
Nektar Therapeutics (NASDAQ:NKTR) CFO Gil M. Labrucherie sold 6,245 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $19.67, for
Did Hedge Funds Make The Right Call On Nektar Therapeutics (NKTR) ?
01:42pm, Wednesday, 12'th Aug 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Vaccibody AS and Nektar Therapeutics (NASDAQ: NKTR) today announced that the first patient has been dosed in the combination therapy of the Phase 1/2a study evaluating bempegaldesleukin (bempeg), Nekt
Nektar's (NKTR) Q2 Earnings Beat, Bempeg Makes Progress
03:35pm, Friday, 07'th Aug 2020
Nektar (NKTR) reports encouraging second-quarter 2020 results. The company continues to progress with its pipeline candidates.
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
11:00pm, Thursday, 06'th Aug 2020
Nektar (NKTR) delivered earnings and revenue surprises of 34.78% and 113.84%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Nektar Therapeutics Reports Second Quarter 2020 Financial Results
08:15pm, Thursday, 06'th Aug 2020
Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2020.
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
If You Had Bought Nektar Therapeutics (NASDAQ:NKTR) Stock Five Years Ago, You Could Pocket A 106% Gain Today
03:15pm, Wednesday, 05'th Aug 2020
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far...
Nektar Therapeutics (NASDAQ:NKTR) Shares Acquired by Nisa Investment Advisors LLC
08:30am, Wednesday, 05'th Aug 2020
Nisa Investment Advisors LLC lifted its holdings in shares of Nektar Therapeutics (NASDAQ:NKTR) by 84.8% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
